tesamorelin cjc-1295 ipamorelin combination safety vs. CJC 1295: Key Comparisons Explained Tesamorelin+cjc-1295+ipamorelin 6/3/3 mg, Injection at

Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma

Dosch SF, Mahajan SD, Collins AR

It remains unresolved whether reduced frataxin triggers ferroptosis by inhibiting ironsulfur cluster synthesis enzymes (such as NFS1 and ISCU) and disrupting mitochondrial iron homeostasis, nor is it known how lipid peroxidation products generated during ferroptosis further impair frataxin function and exacerbate ironsulfur cluster assembly defects

The short answer is yes, but only if you choose wisely